001     201266
005     20240625095111.0
024 7 _ |2 doi
|a 10.1021/jm100882t
024 7 _ |2 ISSN
|a 0022-2623
024 7 _ |2 ISSN
|a 0095-9065
024 7 _ |2 ISSN
|a 1520-4804
024 7 _ |2 ISSN
|a 1943-2992
024 7 _ |2 WOS
|a WOS:000284287200029
037 _ _ |a FZJ-2015-03571
082 _ _ |a 540
100 1 _ |0 P:(DE-HGF)0
|a Bongarzone, Salvatore
|b 0
245 _ _ |a Parallel Synthesis, Evaluation, and Preliminary Structure−Activity Relationship of 2,5-Diamino-1,4-benzoquinones as a Novel Class of Bivalent Anti-Prion Compound
260 _ _ |a Washington, DC
|b ACS
|c 2010
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1433834621_26784
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a A library of 11 entries, featuring a 2,5-diamino-1,4-benzoquinones nucleus as spacer connecting two aromatic prion recognition motifs, was designed and evaluated against prion infection. Notably, 6-chloro-1,2,3,4-tetrahydroacridine 10 showed an EC50 of 0.17 μM, which was lower than that displayed by reference compound BiCappa. More importantly, 10 possessed the capability to contrast prion fibril formation and oxidative stress, together with a low cytotoxicity. This study further corroborates the bivalent strategy as a viable approach to the rational design of anti-prion chemical probes.
536 _ _ |0 G:(DE-HGF)POF2-899
|a 899 - ohne Topic (POF2-899)
|c POF2-899
|x 0
|f POF I
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |0 P:(DE-HGF)0
|a Tran, Hoang Ngoc Ai
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Cavalli, Andrea
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Roberti, Marinella
|b 3
700 1 _ |0 P:(DE-Juel1)145614
|a Carloni, Paolo
|b 4
|u fzj
700 1 _ |0 P:(DE-HGF)0
|a Legname, Giuseppe
|b 5
|e Corresponding Author
700 1 _ |0 P:(DE-HGF)0
|a Bolognesi, Maria Laura
|b 6
|e Corresponding Author
773 _ _ |0 PERI:(DE-600)1491411-6
|a 10.1021/jm100882t
|g Vol. 53, no. 22, p. 8197 - 8201
|n 22
|p 8197 - 8201
|t Journal of medicinal chemistry
|v 53
|x 1520-4804
|y 2010
856 4 _ |u https://juser.fz-juelich.de/record/201266/files/jm100882t.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201266/files/jm100882t.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201266/files/jm100882t.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201266/files/jm100882t.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201266/files/jm100882t.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201266/files/jm100882t.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:201266
|p VDB
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)145614
|a Forschungszentrum Jülich GmbH
|b 4
|k FZJ
913 2 _ |0 G:(DE-HGF)POF3-899
|1 G:(DE-HGF)POF3-890
|2 G:(DE-HGF)POF3-800
|a DE-HGF
|b Forschungsbereich Materie
|l Forschungsbereich Materie
|v ohne Topic
|x 0
913 1 _ |0 G:(DE-HGF)POF2-899
|1 G:(DE-HGF)POF2-890
|2 G:(DE-HGF)POF2-800
|a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|v ohne Topic
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0310
|2 StatID
|a DBCoverage
|b NCBI Molecular Biology Database
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)GRS-20100316
|k GRS
|l GRS
|x 0
920 1 _ |0 I:(DE-Juel1)IAS-5-20120330
|k IAS-5
|l Computational Biomedicine
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)GRS-20100316
980 _ _ |a I:(DE-Juel1)IAS-5-20120330
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)INM-9-20140121
981 _ _ |a I:(DE-Juel1)IAS-5-20120330


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21